Year |
Citation |
Score |
2018 |
Gomez Limia CE, Devalle S, Reis M, Sochacki J, Madeiro da Costa R, D'Andrea M, Padilha T, Zalcberg IR, Solza C, Daumas A, Rehen S, Bonamino MH, Monte-Mór B. Characterization of a human induced Pluripotent Stem (iPS) cell line (INCABRi002-A) derived from a primary myelofibrosis patient harboring the 5-bp insertion in CALR and the p.W146X mutation in TP53. Stem Cell Research. 33: 130-134. PMID 30343103 DOI: 10.1016/J.Scr.2018.09.012 |
0.605 |
|
2017 |
Gomez Limia CE, Devalle S, Reis M, Sochacki J, Carneiro M, Madeiro da Costa R, D'Andrea M, Padilha T, Zalcberg IR, Solza C, Daumas A, Rehen S, Monte-Mór B, Bonamino MH. Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52bp deletion and the ASXL1 p.R693X mutation. Stem Cell Research. 24: 16-20. PMID 29034885 DOI: 10.1016/J.Scr.2017.08.006 |
0.597 |
|
2016 |
Sochacki J, Devalle S, Reis M, Fontenelle LF, Rehen S. Generation of urine iPS cell line from a patient with obsessive-compulsive disorder using a non-integrative method. Stem Cell Research. 17: 107-110. PMID 27558612 DOI: 10.1016/J.Scr.2016.05.018 |
0.616 |
|
2016 |
Sochacki J, Devalle S, Reis M, Mattos P, Rehen S. Generation of urine iPS cell lines from patients with Attention Deficit Hyperactivity Disorder (ADHD) using a non-integrative method. Stem Cell Research. 17: 102-106. PMID 27558611 DOI: 10.1016/J.Scr.2016.05.015 |
0.6 |
|
2016 |
Sochacki J, Devalle S, Reis M, de Moraes Maciel R, da Silveira Paulsen B, Brentani H, Belmonte-de-Abreu PS, Rehen S. Generation of iPS cell lines from schizophrenia patients using a non-integrative method. Stem Cell Research. 17: 97-101. PMID 27558610 DOI: 10.1016/J.Scr.2016.05.017 |
0.605 |
|
2008 |
Swanson KD, Winter JM, Reis M, Bentires-Alj M, Greulich H, Grewal R, Hruban RH, Yeo CJ, Yassin Y, Iartchouk O, Montgomery K, Whitman SP, Caligiuri MA, Loh ML, Gilliland DG, et al. SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients. Genes, Chromosomes & Cancer. 47: 253-9. PMID 18064648 DOI: 10.1002/Gcc.20527 |
0.311 |
|
Show low-probability matches. |